Literature DB >> 14084700

A CLINICAL STUDY OF ISONIAZID INACTIVATION.

A G JESSAMINE, E J HAMILTON, L EIDUS.   

Abstract

The rate of inactivation of isoniazid (INH) in a host organism varies widely, probably because of genetic factors. A simple chemical test was used to determine INH levels in 24 tuberculous patients three and six hours after oral administration of the drug. Results are expressed in terms of half-life values of free INH in the body. Seven of the 24 patients inactivated INH rapidly (half-life average: 64 minutes); the remaining 17 metabolized INH at a slower rate (half-life average: 186 minutes). The range of individual half-life values was 30 to 305 minutes. A provisional half-life limit of 110 minutes was used to define "fast inactivators"; 110-160 minutes, "moderate inactivators"; and over 160 minutes, "slow inactivators". Although INH inactivation may not be directly related to therapeutic failure, the security margin of the treatment may be diminished in those patients who inactivate INH rapidly.

Entities:  

Keywords:  BLOOD; EXPERIMENTAL LAB STUDY; ISONIAZID; METABOLISM; PHARMACOLOGY; TUBERCULOSIS

Mesh:

Substances:

Year:  1963        PMID: 14084700      PMCID: PMC1922160     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.

Authors:  J W JENNE; F M MACDONALD; E MENDOZA
Journal:  Am Rev Respir Dis       Date:  1961-09

2.  Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications.

Authors:  H W HARRIS; R A KNIGHT; M J SELIN
Journal:  Am Rev Tuberc       Date:  1958-12

3.  [On the significance of isoniazid metabolism as a hereditary metabolic characteristic of normal persons].

Authors:  R PFAFFENBERG
Journal:  Klin Wochenschr       Date:  1961-02-15

4.  A critical analysis of the accuracy of a chemical and biologic method of determining serum free isoniazid.

Authors:  S J BERTE; H C LEIFHEIT; H J DEWLETT; E B TUCKER
Journal:  Am Rev Tuberc       Date:  1959-03

5.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

6.  Effect of certain aromatic amines on serum isoniazid concentrations in tuberculous patients.

Authors:  J C BELL; D K RIEMENSNIDER; R S MITCHELL
Journal:  Am Rev Tuberc       Date:  1957-07

7.  Clinical implications of isoniazid blood levels in pulmonary tuberculosis.

Authors:  R S MITCHELL; J C BELL
Journal:  N Engl J Med       Date:  1957-11-28       Impact factor: 91.245

8.  Inhibition of isoniazid acetylation in vitro and vivo.

Authors:  W JOHNSON; G CORTE
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

9.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.

Authors:  P R GANGADHARAM; S DEVADATTA; W FOX; C N NAIR; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

10.  Detection and identification of some metabolites of isonicotinic acid hydrazide (isoniazid) in human urine.

Authors:  W F CUTHBERTSON; D M IRELAND; W WOLFF
Journal:  Biochem J       Date:  1953-11       Impact factor: 3.857

View more
  4 in total

Review 1.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

2.  Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1973-09-15       Impact factor: 8.262

3.  Inactivation of isoniazid by Canadian Eskimos and Indians.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

Review 4.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.